Ranbaxy Can't Dodge Lupin's Suit Over Generic Antara
A Pennsylvania federal judge on Thursday rejected Ranbaxy Laboratories Ltd.'s bid to nix a Lupin Ltd. unit's lawsuit seeking to block Ranbaxy from launching a generic version of the cholesterol drug...To view the full article, register now.
Already a subscriber? Click here to view full article